Clinical Trial: A Multicenter, Single-Arm, Prospective Clinical Trial of Arterial Infusion Chemotherapy Embolization Combined with Dual Immune Checkpoint Inhibitors as First-Line Treatment for Liver Metastases from Pancreatic Cancer (China)

China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Single-Arm, Prospective Clinical Trial of Arterial Infusion Chemotherapy Embolization Combined with Dual Immune Checkpoint Inhibitors as First-Line Treatment for Liver Metastases from Pancreatic Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133048

Registration Time: 2026/09/21

Type: Interventional study

Primary Sponsor: Shandong Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344543

Published by HT Digital Content Services with permission from Health Daily Digest....